SORT BY Relevancy
Dr. Roger Tiedemann is a scientist at the Ontario Cancer Institute and a hematologist specializing in multiple myeloma and lymphoma within the division of Medical Oncology and Hematology at the Princess Margaret Cancer Center and is an Assistant Professor of Medicine at the University of Toronto with appointments from the Department of Medical Biophysics and in the Department of Medicine. Dr. Tiedemann is a New Zealand-trained hematologist and fellow of both the Royal Australasian College of Physicians and the Royal College of Pathologists of Australasia. Hes an author of a US patent application for a new cell cycle therapeutic. His research focus includes multiple myeloma stems, progenitor cells, genomics and the development of new therapeutic strategies for myeloma based on an understanding of the tumor biology.
RSVP here! (or) mail email@example.com
Our guest today is Bob Dobbins, Vice President, New Business Development at Panasonic Corporation of North America. We will be talking to him today about Panasonic's upcoming Innovation HealthJam.
The Innovation HealthJam is a completely virtual event that brings together a diverse and knowledgeable group of people from the healthcare and technology fields to brainstorm ideas, improvements and innovation in healthcare. The event is co-hosted by a group of healthcare industry leaders and led by Panasonic's Innovation Group. Sponsors include leading healthcare industry organizations:
The American Medical Association
The Center for Technology and Aging
The Center for Information Technology Research in the Interest of Society (CITRIS)
Healthcare Information and Management Systems Society (HIMSS)
Personal Connected Health Alliancs (PCHA), a collaboration between Continua Health Alliance, mHealth Summit and HIMSS; along with technology providers Intel and Panasonic, and academic institutions UC Davis and UCSF
There are eight focus areas for the Jam:
Patient Engagement and Healthcare Design for Consumers
Technology and Older Adults: The New Era of Connected Aging
A Mobile Health Agenda for Transforming Healthcare Delivery
Compute for Personalized Medicine: Finding the Cause and Cure through Genomics
Telehealth and Telemedicine: Emerging Opportunities in Addressing the Triple Aim
Your Physician of the Future
Health Innovation for Vulnerable Populations - Worldwide
Remote Patient Monitoring (RPM)
Join us for an exciting discussion - Mr. Dobbins will be taking questions on air.
This episode is sponsored by Panasonic USA.
DNA mapping is it the gateway for Eugenics? Can we trust those who have used us?
"Assessing the work of Charles Darwin, and pondering the experience of animal breeders and horticulturists, Francis Galton wondered if the human genetic make-up could be improved: “The question was then forced upon me - Could not the race of men be similarly improved? Could not the undesirables be got rid of and the desirables multiplied?”This concept of eugenics - a term he introduced - soon won many adherents, notably in North America and England. First practical steps were taken in the United States of America. The government under Theodore Roosevelt created a national Heredity Commission that was charged to investigate the genetic heritage of the country and to “(encourage) the increase of families of good blood and (discourage) the vicious elements in the cross-bred American civilization”.
Don't be Educated in Ignorance!
Join in the conversation on I was just thinking... brought to you by the Caribbean Radio Show-The Knowlwdge Station every Friday evening 5-7pm pacific time and 8-10pm eastern time.
Learn why myeloma is so genetically complicated and the implications this has for personalized medicine in myeloma. Dr. Lohr, MD, PhD of the Dana Farber Cancer Institute and BROAD Institue recently published an article in Cancer Cell describing the complexity and what it means for myeloma patients.
This week I have the pleasure of interviewing the physician who mentored me in Integrative Medicine, Dr. Ronald Ciccone. And look for a SPECIAL ANNOUNCEMENT at the end of the show.
Born and raised in the Philadelphia area, Dr. Ciccone graduated Magna Cum Laude in Biology from St Joseph's University. He earned his Medical Degree at Hahnemann University School of Medicine and completed a traditional three year Family Practice Residency at Delaware County Memorial Hospital in Drexel Hill, Pa., serving as Chief Resident in his last year of training. For more than 23 years, he has been practicing Family Medicine and Integrating Alternative Care.
Dr. Ciccone has a broad-based knowledge of Alternative/Complementary Health Care and is receptive to listening to your treatment and preventative care suggestions. He will do his best to integrate your suggestions where possible with mainstream allopathic medicine, and does not pretend to be an expert in any one field of alternative health care, however, he networks with Holistic Practitioners and will provide referrals where and when they seem appropriate.
Dr. Ciccone's philosophy is to blend alternative/complementary care with mainstream allopathic medicine.
Dr. Ciccone provides a wide variety of medical treatments that incorporate both mainstream and complementary modalities including Integrative Health Care, Chelation & Intravenous Supplementation, Predictive Genomics - Personal Genetic Testing, Neurotransmitters
Listen to cytogenetics and genomics expert Dr. Rafael Fonseca, MD of the Mayo Clinic in Scottsdale share the latest in his myeloma research and his open clinical trials.
The month of November is renamed Movember for men's health. This a special show on a special day - Wedensday.
Today is a special show against Cancer, we have Dr. Donovan and Shukmei Ho, Ph.D. to talk about Men's Health and why we deserve to have a National Cancer Institute-designated cancer center. The institute’s demand for innovative discovery, novel clinical trials and high impact prevention studies will elevate patient survival and bring new venues of economic growth to the Greater Cincinnati.
Shukmei Ho, Ph.D. is a Jacob G. Schmidlapp Professor & Chair in Enivironmental Health, Director, Center for Environmental Genetics, Director, G at Genomics & Sequencing Core at University of Cincinnati, Director, Cincinnati Cancer Center.
Dr. James Donovan is Chief of Div of Urology at UC Surgeons.
The month of November is renamed Movember for men's health.
The show will streamed live on Wedensday November 13th at 4 PM. Listen to this link: http://tobtr.com/s/5616593
On the Wednesday, July 24th, 2013 broadcast at 2PM Pacific/5PM Eastern our special guest is entrepreneur, social media thought leader and Forbes Contributor Dan Munro aka @danmunro.
Dan recently penned a piece for Forbes titled: 'Big Government Opens Big Database For Cancer Research'
This catchy headline caught my attention since part of our mission at This Week In Oncology is to eliminate the esoterica from 'oncology-speak' and to present the significance of the discoveries, trends and developments in the cancer care and diagnostics in plain english for more general consumption.
Much progress has been realized in oncology of late with a fair amount of the promisesd upside of 'personalized [or individualized] medicine' often pointing to better outcomes via more targeted treatment of specific tumors based on their unique genetic signature.
So called 'big data' is in the news as ubiquitous technology, connectivity, the declining costs of massive data dragnets and disease specific mashups affords insights previously inaccessible to reseachers, clinicians and others interested in the diagnosis and/or treatment of oncology.
We'll get Dan's takes on his piece and see how he sees the confluence of these trends coming together for the benefits of patients.
in Self Help
Sky Christopherson is an internet entrepreneur, award-winning filmmaker, and world class athlete.
Called a "Wunderkind" by The New York Times, Sky was an athlete on the U.S. Cycling Team. Sky was member of the top-secret 'Project 96' Olympic training program, World Medal Finalist and alternate on the 1996 and 2000 U.S. Olympic Teams. Sky currently holds a world record on the velodrome.
After graduating from the University of California San Diego in 2006,
Sky founded Vicaso.com in Seattle, WA. Vicaso is a high dynamic range imaging platform that has generated over $4 million in revenues and helped sell over 19,000 homes in 12 major U.S. real estate markets.
Co-founder of Optimized Athlete, Sky leveraged advances in biotechnology including genomics and wireless tenchnology to help athletes win medals at the 2012 London Olympics.
Sky also enjoys a passion for filmmaking. He directed and shot The Greater Meaning of Water, a feature length film about a breath-hold freediver (think: 'The Big Blue'). The film won 'Best Spiritual Film' at the Amsterdam International Film Festival and is now available on Amazon.com
Real-time detection of pathogens using customized nanoparticle biosensors with Fred Byerlein, MBA & Houng-Yau Mei, Ph.D., MBA
Mr. Beyerlein has over 30 years of extensive experience in early stage enterprise development product and market strategy, financial systems and overall business strategy. Mr. Beyerlein currently serves as the CEO of nanoRETE, Inc.; a biosensor development company focused on pathogen and toxin detection within the food safety and supply markets. Mr. Beyerlein received his MBA in Economics and Finance from Fordham University.
Dr. Mei received his Ph.D. degree from Columbia University followed by a NIH-postdoctoral fellowship at the University of California and an Executive MBA from Michigan State University. He has worked at Pfizer and Parke-Davis Pharmaceuticals, Rubicon Genomics, and Neural Intervention Technologies. Dr. Mei has over 60 patent applications, publications & abstracts..
Agenda: 1. Introduction. 2. What are human pathogens, such as anthrax, E. Coli, salmonella, tuberculosis? 3. What are the traditional methods of detection? 4. Is there a need for in-field, rapid testing results? 5. What is bio-barcode technology? a. Nano particle-presence/absence metal-ion 6. What advantages does multiplex testing offer? 7. What is square wave anodic stripping voltammetry (SWASV)? 8. Why is the reporting of test results within an hour advantageous? 9. What is the price of these new technologies? 10. Conclusion.
Contact: Fred Beyerlein, BS/MBA Chief Executive Officer nanoRETE, Inc. 3815 Technology Blvd. #1050 Lansing, MI 48910 517.336.4680 firstname.lastname@example.org http://www.nanorete.com
Join Host Live Chats
- Black Swan Radio (16 chatters)